Catubig, Mercy S.

HRN: 01-63-74  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2022
CO-AMOXICLAV 625MG (TAB)
07/28/2022
08/03/2022
PO
625mg
BID
Acute Cystitis
Waiting Final Action 
07/30/2022
CEFTRIAXONE 1G (VIAL)
07/30/2022
08/05/2022
IV
2g
OD
Gastritis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: